Arrythmias: Atrial Fibrillation Flashcards

1
Q

What is atrial fibrillation (AF)?

A

Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia, present in around 5% of patients over aged 70-75 years and 10% of patients aged 80-85 years.

characterised by disorganised electrical activity in the atria, leading to ineffective atrial contraction and an irregularly irregular ventricular response.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are the main management goals for patients with AF?

A

The most important aspect of managing patients with AF is reducing the increased risk of stroke.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

How is AF classified?

A

AF may be classified as first detected episode, paroxysmal, persistent, or permanent.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is paroxysmal AF?

A

Paroxysmal AF refers to episodes that terminate spontaneously and last less than 7 days, typically less than 24 hours.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are the symptoms of AF?

A

Symptoms include palpitations, dyspnoea, and chest pain.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is a key sign of AF?

A

An irregularly irregular pulse is a key sign of AF.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is essential for diagnosing AF?

A

An ECG is essential to make the diagnosis of AF.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What are the two key parts of managing AF?

A

The two key parts of managing patients with AF are rate/rhythm control and reducing stroke risk.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is rate control in AF management?

A

Rate control involves accepting an irregular pulse while slowing the rate to avoid negative effects on cardiac function.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is rhythm control in AF management?

A

Rhythm control aims to restore and maintain normal sinus rhythm, which may involve pharmacological or electrical cardioversion.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is the CHA2DS2-VASc score used for?

A

The CHA2DS2-VASc score is used to determine the most appropriate anticoagulation strategy based on stroke risk.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What anticoagulation strategy is suggested for a CHA2DS2-VASc score of 0?

A

No treatment is suggested for a CHA2DS2-VASc score of 0.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What anticoagulation strategy is suggested for a CHA2DS2-VASc score of 1?

A

For a score of 1, males should consider anticoagulation, while females should not receive treatment.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What anticoagulation strategy is suggested for a CHA2DS2-VASc score of 2 or more?

A

For a score of 2 or more, anticoagulation should be offered.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What are the first-line medications for rate control in AF?

A

A beta-blocker or a rate-limiting calcium channel blocker (e.g., diltiazem) is used first-line for rate control.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What must be considered before cardioversion in AF?

A

Patients must have had a short duration of symptoms (less than 48 hours) or be anticoagulated prior to attempting cardioversion due to the risk of embolism.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What did NICE update in 2021 regarding atrial fibrillation?

A

NICE updated their guidelines on the management of atrial fibrillation (AF).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Who should be assessed for anticoagulation in atrial fibrillation?

A

Patients with any history of AF, including symptomatic or asymptomatic paroxysmal, persistent or permanent AF, atrial flutter, and those with a continuing risk of arrhythmia recurrence.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What scoring system does NICE suggest for determining anticoagulation strategy?

A

NICE suggests using the CHA2DS2-VASc score.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

What score indicates no need for anticoagulation?

A

A CHA2DS2-VASc score of 0 indicates no treatment is needed.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

What is the anticoagulation recommendation for a CHA2DS2-VASc score of 1?

A

Males: Consider anticoagulation; Females: No treatment.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

What should be done if the CHA2DS2-VASc score suggests no anticoagulation?

A

Ensure a transthoracic echocardiogram has been done to exclude valvular heart disease.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

What scoring system does NICE recommend for assessing bleeding risk?

A

NICE recommends using the ORBIT scoring system.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

What is the ORBIT score range for low bleeding risk?

A

An ORBIT score of 0-2 indicates low bleeding risk.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

What anticoagulant was traditionally used for atrial fibrillation?

A

Warfarin was the anticoagulant of choice for many years.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

What are the recommended direct oral anticoagulants (DOACs) for AF?

A

Apixaban, dabigatran, edoxaban, and rivaroxaban are recommended DOACs.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

When is warfarin used in the management of AF?

A

Warfarin is used second-line in patients where a DOAC is contraindicated or not tolerated.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

Is aspirin recommended for reducing stroke risk in patients with AF?

A

Aspirin is not recommended for reducing stroke risk in patients with AF.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

What are the two scenarios where cardioversion may be used in atrial fibrillation?

A
  1. Electrical cardioversion as an emergency for haemodynamically unstable patients. 2. Electrical or pharmacological cardioversion as an elective procedure for rhythm control.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

How is electrical cardioversion synchronized?

A

Electrical cardioversion is synchronized to the R wave to prevent shock delivery during the vulnerable period of cardiac repolarisation.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

What does the NICE guideline recommend for onset of arrhythmia less than 48 hours?

A

Offer rate or rhythm control if the onset of the arrhythmia is less than 48 hours, and start rate control if it is more than 48 hours or uncertain.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

What should be done if atrial fibrillation onset is less than 48 hours?

A

Patients should be heparinised. Those with risk factors for ischaemic stroke should receive lifelong oral anticoagulation. Cardioverting options include electrical (DC cardioversion) or pharmacology (amiodarone, flecainide).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

What is the anticoagulation requirement for patients with AF onset greater than 48 hours?

A

Anticoagulation should be given for at least 3 weeks prior to cardioversion.

34
Q

What alternative strategy can be used for patients with AF onset greater than 48 hours?

A

Perform a transoesophageal echo (TOE) to exclude a left atrial appendage (LAA) thrombus. If excluded, patients may be heparinised and cardioverted immediately.

35
Q

What does NICE recommend for cardioversion in patients with AF onset greater than 48 hours?

A

NICE recommends electrical cardioversion rather than pharmacological.

36
Q

What should be done if there is a high risk of cardioversion failure?

A

It is recommended to have at least 4 weeks of amiodarone or sotalol prior to electrical cardioversion.

37
Q

What is the anticoagulation requirement following electrical cardioversion?

A

Patients should be anticoagulated for at least 4 weeks after electrical cardioversion.

38
Q

What is the purpose of the 2012 guidelines by AHA, ACC, and ESC?

A

To simplify and clarify the classification of atrial fibrillation (AF).

39
Q

How many patterns is AF classified into according to the guidelines?

A

AF is classified into 3 patterns.

40
Q

What is the first pattern of AF classification?

A

First detected episode (irrespective of whether it is symptomatic or self-terminating).

41
Q

What defines recurrent episodes of AF?

A

When a patient has 2 or more episodes of AF.

42
Q

What is paroxysmal AF?

A

Episodes of AF that terminate spontaneously and last less than 7 days (typically < 24 hours).

43
Q

What is persistent AF?

A

AF that is not self-terminating and usually lasts greater than 7 days.

44
Q

What is permanent AF?

A

Continuous atrial fibrillation which cannot be cardioverted or if attempts to do so are deemed inappropriate.

45
Q

What are the treatment goals for permanent AF?

A

Rate control and anticoagulation if appropriate.

46
Q

What is atrial fibrillation (AF)?

A

Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia, with 800,000 cases in the UK, many undiagnosed.

47
Q

What are the features of atrial fibrillation?

A

AF may present with palpitations, dyspnoea, dizziness/syncope; many cases are asymptomatic and found incidentally. The pulse is irregularly irregular.

48
Q

How is atrial fibrillation diagnosed?

A

Diagnosis is made via ECG showing absent P waves. A 24-hour ECG or event recorder is useful for suspected paroxysmal AF. Echocardiography is not required in all cases.

49
Q

What are the key elements to managing atrial fibrillation?

A
  1. Reducing the risk of stroke 2. Controlling the heart rate.
50
Q

How is stroke risk assessed in atrial fibrillation?

A

Stroke risk is assessed using the CHA2DS2-VASC scoring system to determine the need for anticoagulation.

51
Q

What is the traditional anticoagulant of choice for AF?

A

Warfarin is the traditional anticoagulant of choice, but Non-Vitamin K Antagonist Oral Anticoagulants (NOACs) have been developed as alternatives.

52
Q

What are the advantages of NOACs over warfarin?

A

NOACs do not require regular monitoring like warfarin, making them more convenient for patients.

53
Q

What are the options for controlling heart rate in AF?

A

Options include restoring normal sinus rhythm or accepting an irregular rhythm but slowing it down to reduce adverse effects of persistent tachycardia.

54
Q

What is the common management strategy for AF?

A

The majority of patients are managed with a rhythm control strategy, as they often revert back to AF after restoration of sinus rhythm.

55
Q

What medications are used to control heart rate in AF?

A

Beta-blockers and calcium channel blockers are used to control the rate, with digoxin as a second-line option.

56
Q

What methods can be used for rhythm control in AF?

A

Rhythm control can be achieved using pharmacological cardioversion, electrical cardioversion, or catheter ablation.

57
Q

What are the guidelines for managing atrial fibrillation (AF)?

A

NICE published guidelines in 2014, based on the joint AHA, ACC, and ESC 2016 guidelines.

58
Q

What agents have proven efficacy in the pharmacological cardioversion of atrial fibrillation?

A

Amiodarone and flecainide (if no structural heart disease) are agents with proven efficacy.

Other less commonly used agents in the UK include quinidine, dofetilide, ibutilide, and propafenone.

59
Q

What are considered less effective agents for atrial fibrillation?

A

Less effective agents include beta-blockers (including sotalol), calcium channel blockers, digoxin, disopyramide, and procainamide.

60
Q

What is atrial fibrillation in relation to stroke?

A

Atrial fibrillation is one of the key risk factors for ischaemic stroke.

61
Q

Why is it important to recognize atrial fibrillation post-stroke?

A

It is important to recognize and treat atrial fibrillation if identified in a patient following a stroke or transient ischaemic attack (TIA).

62
Q

What should be excluded before starting anticoagulation or antiplatelet therapy?

A

It is important to exclude a haemorrhage before starting any anticoagulation or antiplatelet therapy.

63
Q

What does NICE recommend for long-term stroke prevention in atrial fibrillation?

A

NICE recommends warfarin or a direct thrombin or factor Xa inhibitor for long-term stroke prevention.

64
Q

When should anticoagulation for AF start after a TIA?

A

Anticoagulation for AF should start immediately once imaging has excluded haemorrhage following a TIA.

65
Q

When should anticoagulation therapy be commenced in acute stroke patients?

A

In acute stroke patients, anticoagulation therapy should be commenced after 2 weeks in the absence of haemorrhage.

66
Q

What therapy should be given in the intervening period before anticoagulation in acute stroke patients?

A

Antiplatelet therapy should be given in the intervening period before anticoagulation.

67
Q

When should the initiation of anticoagulation be delayed?

A

The initiation of anticoagulation should be delayed if imaging shows a very large cerebral infarction.

68
Q

What are the NICE guidelines on the management of atrial fibrillation (AF)?

A

NICE updated its guidelines on the management of atrial fibrillation (AF) in 2021, based on the joint AHA, ACC, and ESC 2012 guidelines.

69
Q

What should be done for patients with signs of haemodynamic instability presenting with AF?

A

They should be electrically cardioverted, as per the peri-arrest tachycardia guidelines.

70
Q

How is the management of haemodynamically stable patients with AF determined?

A

Management depends on how acute the AF is:
- < 48 hours: rate or rhythm control
- ≥ 48 hours or uncertain: rate control

If considered for long-term rhythm control, delay cardioversion until maintained on therapeutic anticoagulation for a minimum of 3 weeks.

71
Q

What is the first-line treatment strategy for atrial fibrillation?

A

Rate control should be offered as the first-line treatment strategy for atrial fibrillation, except in specific cases.

72
Q

In which cases is rate control not the first-line treatment for AF?

A

Rate control is not first-line in patients with:
- Reversible causes of AF
- Heart failure primarily caused by AF
- New-onset AF (< 48 hours)
- Atrial flutter suitable for ablation
- Clinical judgement favors rhythm-control strategy.

73
Q

What agents are used for rate control in atrial fibrillation?

A

Agents include beta-blockers, calcium channel blockers, and digoxin.

Beta-blockers have a common contraindication of asthma.

74
Q

What is the role of digoxin in rate control for AF?

A

Digoxin is not considered first-line due to less effectiveness during exercise and should only be used if the person does little physical exercise or other options are ruled out due to comorbidities.

75
Q

What agents are used to maintain sinus rhythm in patients with a history of AF?

A

Agents include beta-blockers, dronedarone (second-line after cardioversion), and amiodarone (especially if coexisting heart failure).

76
Q

What does NICE recommend regarding catheter ablation for AF?

A

NICE recommends catheter ablation for patients with AF who have not responded to or wish to avoid antiarrhythmic medication.

77
Q

What is the aim of catheter ablation in AF treatment?

A

The aim is to ablate faulty electrical pathways causing AF, typically due to aberrant electrical activity between the pulmonary veins and left atrium.

78
Q

How is catheter ablation performed?

A

The procedure is performed percutaneously, typically via the groin, using either radiofrequency or cryotherapy.

79
Q

What is the anticoagulation protocol for catheter ablation?

A

Anticoagulation should be used 4 weeks before and during the procedure. It is important to remember that catheter ablation controls rhythm but does not reduce stroke risk.

80
Q

What are the recommendations for anticoagulation based on CHA2DS2-VASc score?

A

If score = 0: 2 months anticoagulation recommended. If score > 1: long-term anticoagulation recommended.

81
Q

What are notable complications of catheter ablation?

A

Notable complications include cardiac tamponade, stroke, and pulmonary vein stenosis.

82
Q

What is the success rate of catheter ablation for AF?

A

Around 50% of patients experience early recurrence of AF within 3 months, which often resolves spontaneously. After 3 years, about 55% of patients who’ve had a single procedure remain in sinus rhythm, and around 80% of those who’ve undergone multiple procedures are in sinus rhythm.